|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
      |
|||||||||||||
 |
 |
|||||||||||||
   
 |
||||||||||||||
News
MiMedx Hires Dr. Long as Senior Scientist
Tampa, Fla. — July 27, 2007 — MiMedx, Inc. announces the hiring of Dr. John H. Long, Jr., Professor of Biology at Vassar College, to serve as its Senior Scientist. Trained in biomechanics at Duke University, Dr. Long will assist MiMedx in the Company's core biomaterials research, bioprosthesis development, and R&D infrastructure management.
A long-time collaborator of Dr. Thomas Koob, MiMedx's Chief Scientific Officer, Dr. Long has expertise in the biomechanical characterization of vertebrate connective tissues and in the modeling of how tendons and ligaments function in association with muscle during complex movements. His laboratory has been funded by the Bioengineering Program of the Office of Naval Research and the Division of Biological Infrastructure at the National Science Foundation. With his experience analyzing and simulating musculo-skeletal systems, Dr. Long will help guide MiMedx in the design of bioprostheses that mimic and extend the mechanical behavior of native tendons and ligaments.
About MiMedx, Inc.
Founded in 2006, MiMedx Inc. (MDX) is a development stage company whose technology focuses on biomaterials for soft tissue repair, such as tendons, ligaments and cartilage, as well as other biomaterial-based products for numerous other medical applications. The company, headquartered in Tampa, Florida, holds an exclusive, worldwide license from the Shriner's Hospital for Children and the University of South Florida Research Foundation for its NDGA technology. MDX is targeting this proprietary technology for a myriad of diverse applications.
###
These statements have not been reviewed by the FDA.
This website is not meant as a substitute for professional medical advice.
|
|
 |
|
